接受胰高血糖素处方的商业保险患者中存在胰高血糖素填补空白的情况。
Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.
机构信息
Department of Pharmacy, Mayo Clinic, Rochester, MN, United States.
Department of Pharmacy, Mayo Clinic Health System, Southeast Minnesota Region, Owatonna, MN, United States.
出版信息
Diabetes Res Clin Pract. 2023 Jun;200:110720. doi: 10.1016/j.diabres.2023.110720. Epub 2023 May 16.
Abstract
Glucagon is critically underutilized, and we explored whether this is due to inadequate glucagon prescribing or the patient's inability to fill prescriptions. Of 216 commercially insured, high-risk individuals with diabetes who were prescribed glucagon in our healthcare system, 142 (65.4%) had a claim indicating its fill within 30 days.
摘要
胰高血糖素的应用严重不足，我们探讨了这种情况是由于开处方时胰高血糖素剂量不足，还是由于患者无法配药。在我们的医疗体系中，有 216 名患有糖尿病且具有高风险的商业保险患者开了胰高血糖素处方，其中 142 名（65.4%）有配药记录，表明在 30 天内配药。
相似文献
1
Gaps in glucagon fills among commercially insured patients receiving a glucagon prescription.接受胰高血糖素处方的商业保险患者中存在胰高血糖素填补空白的情况。
Diabetes Res Clin Pract. 2023 Jun;200:110720. doi: 10.1016/j.diabres.2023.110720. Epub 2023 May 16.
2
Glucagon use by U.S. adults with type 1 and type 2 diabetes.美国 1 型和 2 型糖尿病患者使用胰高血糖素。
J Diabetes Complications. 2021 May;35(5):107882. doi: 10.1016/j.jdiacomp.2021.107882. Epub 2021 Feb 6.
3
GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIA.用于低血糖急诊就诊后的糖尿病患者的胰高血糖素处方。
Endocr Pract. 2018 Oct 2;24(10):861-866. doi: 10.4158/EP-2018-0223. Epub 2018 Jul 23.
4
GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN.1型或2型糖尿病且新开具胰岛素处方患者的胰高血糖素处方模式
Endocr Pract. 2016 Feb;22(2):123-35. doi: 10.4158/EP15831.OR. Epub 2015 Oct 20.
5
Glucagon prescribing and prevention of hospitalization for hypoglycemia in a large health system.在一个大型医疗体系中，胰高血糖素的处方开具情况与低血糖住院预防。
Diabetes Res Clin Pract. 2023 Aug;202:110832. doi: 10.1016/j.diabres.2023.110832. Epub 2023 Jul 13.
6
Hypoglycemic Events in the Emergency Department.急诊科的低血糖事件。
Endocr Pract. 2022 Apr;28(4):372-377. doi: 10.1016/j.eprac.2022.01.006. Epub 2022 Jan 25.
7
Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.2011-2021 年美国糖尿病患者中胰高血糖素的处方和费用。
Diabetes Care. 2023 Mar 1;46(3):620-627. doi: 10.2337/dc22-1564.
8
Glucagon fill rates and cost among children and adolescents with type 1 diabetes in the United States, 2011-2021.美国 2011-2021 年 1 型糖尿病患儿和青少年的胰高血糖素充盈率和费用。
Diabetes Res Clin Pract. 2023 Dec;206:111026. doi: 10.1016/j.diabres.2023.111026. Epub 2023 Nov 23.
9
Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.在一个大型美国管理式医疗人群中，起始用卡格列净与 DPP-4 抑制剂治疗的 2 型糖尿病患者的人口统计学和临床特征。
J Manag Care Spec Pharm. 2015 Dec;21(12):1204-12. doi: 10.18553/jmcp.2015.21.12.1204.
10
Prescription opioid fills following surgical abortion.手术后开具的阿片类药物处方。
Contraception. 2021 Dec;104(6):648-653. doi: 10.1016/j.contraception.2021.07.106. Epub 2021 Jul 28.
引用本文的文献
1
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.1. 改善人群护理与促进健康：2025年糖尿病护理标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S14-S26. doi: 10.2337/dc25-S001.
本文引用的文献
1
'Didn't See the Need': Misperceptions about glucagon from the perspectives of people with diabetes and their caregivers.“没必要”：糖尿病患者及其照护者对胰高血糖素的误解。
Diabet Med. 2023 Jun;40(6):e15084. doi: 10.1111/dme.15084. Epub 2023 Mar 27.
2
Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.2011-2021 年美国糖尿病患者中胰高血糖素的处方和费用。
Diabetes Care. 2023 Mar 1;46(3):620-627. doi: 10.2337/dc22-1564.
3
Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons.在大多数国家，胰高血糖素在严重低血糖症中的使用很少见，并且尚未因新的即用型胰高血糖素而得到推广。
Diabetol Metab Syndr. 2022 Dec 23;14(1):193. doi: 10.1186/s13098-022-00950-6.
4
6. Glycemic Targets: Standards of Care in Diabetes-2023.6. 血糖目标：2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
5
Trends in Out-of-Pocket Cost of Glucagon, 2010-2020.2010-2020 年胰高血糖素自付费用趋势。
JAMA Netw Open. 2022 Aug 1;5(8):e2229428. doi: 10.1001/jamanetworkopen.2022.29428.
6
Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States.美国在新冠疫情期间的糖尿病护理和血糖控制。
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414. doi: 10.1001/jamainternmed.2021.3047.
7
Glucagon use by U.S. adults with type 1 and type 2 diabetes.美国 1 型和 2 型糖尿病患者使用胰高血糖素。
J Diabetes Complications. 2021 May;35(5):107882. doi: 10.1016/j.jdiacomp.2021.107882. Epub 2021 Feb 6.
8
The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan.在日本，儿科医生和内科医生开出的低血糖用胰高血糖素处方率较低。
Endocrine. 2019 May;64(2):233-238. doi: 10.1007/s12020-018-1793-z. Epub 2018 Oct 26.
9
GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN.1型或2型糖尿病且新开具胰岛素处方患者的胰高血糖素处方模式
Endocr Pract. 2016 Feb;22(2):123-35. doi: 10.4158/EP15831.OR. Epub 2015 Oct 20.
Zotero 插件